Alexandra M. Simond

Point-activated ESR1Y541S has a dramatic effect on the development of sexually dimorphic organs

W. Muller, M. J. Moore, M. Richer, 2020, Genes & development.

The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment

O. Griffith, G. Mills, J. Gray, 2016, Oncogene.

In vivo modeling of the EGFR family in breast cancer progression and therapeutic approaches.

W. Muller, Alexandra M. Simond, 2020, Advances in cancer research.

ErbB2-positive mammary tumors can escape PI3K-p110α loss through downregulation of the Pten tumor suppressor

Jean J. Zhao, W. Muller, D. Zuo, 2017, Oncogene.

Physiological expression of PI3K H1047R mutation reveals its anti-metastatic potential in ErbB2-driven breast cancer

R. Cardiff, W. Muller, W. Phillips, 2022, Oncogene.